Bill > S253

This bill, the Cannabidiol and Marihuana Research Expansion Act, aims to expand research on cannabidiol (CBD) and marijuana. The key provisions of the bill include: 1. Streamlining the process for practitioners to register with the Attorney General to conduct research on marijuana, including allowing them to amend research protocols without reapplying in certain circumstances. 2. Establishing a process for the Attorney General to approve applications to manufacture marijuana for research purposes within 60 days. 3. Allowing appropriately registered institutions of higher education, practitioners, and manufacturers to manufacture, distribute, dispense, or possess marijuana or CBD for the purpose of medical research for drug development or commercial production of FDA-approved drugs. 4. Authorizing the importation of marijuana or CBD for approved medical research or to manufacture FDA-approved drugs. 5. Prohibiting the reinstatement of an interdisciplinary review process for non-NIH funded marijuana researchers. 6. Requiring the Secretary of Health and Human Services to report on the potential therapeutic effects of CBD and marijuana, the effects of increasing THC levels, and the barriers to researching these substances in states where they are legal.

Justice

https://www.congress.gov/bill/117th-congress/senate-bill/253/all-info